Osilodrostat in Cushing's disease: The risk of delayed adrenal insufficiency should be carefully monitored

被引：13
|
作者：
Castinetti, Frederic [1 ]
Amodru, Vincent [1 ]
Brue, Thierry [1 ]
机构：
[1] Aix Marseille Univ, La Conception Hosp, AP HM, INSERM,MMG,Marmara Inst,Dept Endocrinol, Marseille, France
来源：
CLINICAL ENDOCRINOLOGY | 2023年 / 98卷 / 04期
关键词：
Adrenal; adrenal insufficiency; cortisol; Cushing's disease; Pituitary; steroidogenesis inhibitor; 11-BETA-HYDROXYLASE INHIBITOR; MULTICENTER; EFFICACY; SAFETY;
D O I：
10.1111/cen.14551
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Antisecretory data shows a highly effective and prolonged blockade of cortisol secretion with osilodrostat. The drawback is the occurrence of adrenal insufficiency (AI) in roughly a quarter of treated patients. In this short manuscript, we report three cases of atypical adrenal insufficiency with osilodrostat.
引用
收藏
页码：629 / 630
页数：2
相关论文
共 50 条
  • [21] Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome
    Alessandro Prete
    Rosa Maria Paragliola
    Filomena Bottiglieri
    Carlo Antonio Rota
    Alfredo Pontecorvi
    Roberto Salvatori
    Salvatore Maria Corsello
    Endocrine, 2017, 55 : 969 - 980
  • [22] Osteopathy in mild adrenal Cushing's syndrome and Cushing disease
    Frara, Stefano
    Allora, Agnese
    di Filippo, Luigi
    Formenti, Anna Maria
    Loli, Paola
    Polizzi, Elisabetta
    Tradati, Daniele
    Ulivieri, Fabio Massimo
    Giustina, Andrea
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (02)
  • [23] Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency
    Ceccato, Filippo
    Barbot, Mattia
    Zilio, Marialuisa
    Ferasin, Sergio
    Occhi, Gianluca
    Daniele, Andrea
    Mazzocut, Sara
    Iacobone, Maurizio
    Betterle, Corrado
    Mantero, Franco
    Scaroni, Carla
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (01) : 31 - 36
  • [24] DexamethasoneIatrogenic Cushing's syndrome and secondary adrenal insufficiency: case report
    Reactions Weekly, 2023, 1958 (1) : 184 - 184
  • [25] Utility of Salivary Cortisol Measurements in Cushing's Syndrome and Adrenal Insufficiency
    Raff, Hershel
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10): : 3647 - 3655
  • [26] Cushing’s disease: adrenal steroidogenesis inhibitors
    Rosario Pivonello
    Chiara Simeoli
    Nicola Di Paola
    Annamaria Colao
    Pituitary, 2022, 25 : 726 - 732
  • [27] Cushing's disease: adrenal steroidogenesis inhibitors
    Pivonello, Rosario
    Simeoli, Chiara
    Di Paola, Nicola
    Colao, Annamaria
    PITUITARY, 2022, 25 (05) : 726 - 732
  • [28] Addison's disease - Adrenal insufficiency should be excluded before thyroxine replacement is started
    Osman, IA
    Leslie, P
    BRITISH MEDICAL JOURNAL, 1996, 313 (7054): : 427 - 427
  • [29] Osilodrostat in Cushing's disease: the management of its efficacy and the pitfalls of post-surgical results
    Antonini, Simone
    Brunetti, Alessandro
    Zampetti, Benedetta
    Boeris, Davide
    Saladino, Andrea
    Cesare Cozzi, Renato
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2022, 2022
  • [30] Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension
    Fleseriu, Maria
    Newell-Price, John
    Pivonello, Rosario
    Shimatsu, Akira
    Auchus, Richard J.
    Scaroni, Carla
    Belaya, Zhanna
    Feelders, Richard A.
    Vila, Greisa
    Houde, Ghislaine
    Walia, Rama
    Izquierdo, Miguel
    Roughton, Michael
    Pedroncelli, Alberto M.
    Biller, Beverly M. K.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 187 (04) : 531 - 541
12345